omeprazole and cc-292

omeprazole has been researched along with cc-292 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, Y; Li, Y; Liu, L; Xue, Y; Zhou, S	1

Trials

1 trial(s) available for omeprazole and cc-292

Article	Year
An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton's Tyrosine Kinase Inhibitor. European journal of drug metabolism and pharmacokinetics, 2022, Volume: 47, Issue:4 Topics: Acrylamides; Administration, Oral; Area Under Curve; Biological Availability; Cross-Over Studies; Fasting; Food-Drug Interactions; Humans; Hydrogen-Ion Concentration; Omeprazole; Protein Kinase Inhibitors; Pyrimidines; Tablets	2022

Article

Year

An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton's Tyrosine Kinase Inhibitor.

European journal of drug metabolism and pharmacokinetics, 2022, Volume: 47, Issue:4

Topics: Acrylamides; Administration, Oral; Area Under Curve; Biological Availability; Cross-Over Studies; Fasting; Food-Drug Interactions; Humans; Hydrogen-Ion Concentration; Omeprazole; Protein Kinase Inhibitors; Pyrimidines; Tablets

2022